Mia's Feed
Medical News & Research

Radiotherapy for Breast Cancer May Lower Short-Term Alzheimer’s Risk

Radiotherapy for Breast Cancer May Lower Short-Term Alzheimer’s Risk

Share this article

Recent studies suggest that radiotherapy for breast cancer may reduce short-term risk of Alzheimer’s, opening new avenues in cognitive health research.

1 min read

Radiotherapy for breast cancer linked to lower Alzheimer’s risk

Radiotherapy, a common treatment for breast cancer, may offer short-term protection against Alzheimer’s disease, according to recent research. A study led by Samsung Medical Center in South Korea analyzed data from nearly 70,000 breast cancer survivors, finding that those treated with radiation had an 8% lower risk of developing Alzheimer’s compared to women without cancer. The protective effect was most prominent shortly after treatment but seemed to diminish over time.

The findings, published in JAMA Network Open, suggest that radiation therapy might influence neuroprotective mechanisms, potentially reducing inflammation and neurodegeneration pathways. Experts emphasize that while these results are promising, longer-term studies are needed to fully understand the relationship between cancer treatments and Alzheimer’s risk.

This research opens new avenues for exploring how certain cancer therapies could impact cognitive health, highlighting the importance of personalized treatment approaches and the need for further investigation into long-term effects.

Stay Updated with Mia's Feed

Get the latest health & wellness insights delivered straight to your inbox.

How often would you like updates?

We respect your privacy. Unsubscribe at any time.

Related Articles

Lab-grown Mini-Intestines Unveil How Shigella Bacteria Infect Human Gut Tissue

Uppsala University researchers have used lab-grown mini-intestines to map how Shigella bacteria invade human gut tissue, revealing new targets for infection control and showcasing the potential of cultured human organs in infectious disease research.

New Potent Synthetic Opioid Poses Elevated Overdose Risks

A newly detected synthetic opioid, belonging to the nitazene class, is significantly more potent than morphine and fentanyl, raising serious overdose concerns. Rapid detection efforts aim to prevent harm.